<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Xanthogranulomatous pyelonephritis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Xanthogranulomatous pyelonephritis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Xanthogranulomatous pyelonephritis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alain Meyrier, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen B Calderwood, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Allyson Bloom, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 28, 2021.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Xanthogranulomatous pyelonephritis (XPN) is an unusual variant of chronic pyelonephritis. Most cases occur in the setting of obstruction due to infected renal stones [<a href="#rid1">1-6</a>]. Affected patients usually have massive destruction of the kidney due to granulomatous tissue containing lipid-laden macrophages; the appearance may be confused with renal malignancy.</p><p>Studies performed in the 1970s found XPN in 8.2 percent of kidneys surgically removed or biopsied for chronic pyelonephritis and in as many as 25 percent in patients with pyonephrosis [<a href="#rid1">1,7</a>].</p><p class="headingAnchor" id="H2"><span class="h1">CLINICAL PRESENTATION</span><span class="headingEndMark"> — </span>The clinical picture of XPN is somewhat different in adults and children.</p><p class="headingAnchor" id="H3"><span class="h2">Adults</span><span class="headingEndMark"> — </span>XPN most often occurs in middle-aged women with a history of recurrent urinary tract infections [<a href="#rid2">2</a>]. The typical presenting symptoms include flank pain, fever, malaise, anorexia and weight loss. A unilateral renal mass can usually be palpated on physical examination. Blood tests reveal nonspecific abnormalities including anemia, an increased erythrocyte sedimentation rate, and liver function abnormalities reflecting mild biliary retention.</p><p>Examination of the urine confirms the presence of urinary tract infection. The urinalysis reveals pyuria and bacteriuria. Urine culture<strong> </strong>typically demonstrates Enterobacteriaceae. The most common organisms associated with XPN are <em>Escherichia coli</em>, <em>Proteus mirabilis</em>, <em>Pseudomonas</em>, <em>Enterococcus faecalis</em>,<em> </em>and <em>Klebsiella</em> [<a href="#rid6">6</a>]. The urine cultures are sterile in 25 percent of cases [<a href="#rid4">4</a>].</p><p class="headingAnchor" id="H4"><span class="h2">Children</span><span class="headingEndMark"> — </span>There are two different presentations of XPN in children [<a href="#rid4">4,8-10</a>]. The most common form affects boys and girls equally and involves the entire kidney. The other form, which is more frequent in girls, is localized and may mimic a tumor.</p><p>The presenting symptoms include flank and abdominal pain, fever, and growth and weight retardation. Approximately one-half of children have a palpable abdominal mass. Bacteriuria and pyuria are found in 50 to 70 percent of cases with <em>Proteus</em> (60 percent) and <em>E.</em> <em>coli</em> being the most common causative organisms.</p><p class="headingAnchor" id="H5"><span class="h2">Secondary amyloidosis</span><span class="headingEndMark"> — </span>Some patients have a relatively prolonged course of chronic inflammation before the diagnosis of XPN is established. In this setting, secondary amyloidosis (amyloid AA) can occur, leading in some cases to the nephrotic syndrome [<a href="#rid11">11</a>]. (See  <a class="medical medical_review" href="/d/html/5602.html" rel="external">"Causes and diagnosis of AA amyloidosis and relation to rheumatic diseases"</a>.)</p><p class="headingAnchor" id="H6"><span class="h2">Renal transplant recipients</span><span class="headingEndMark"> — </span>Xanthogranulomatous pyelonephritis rarely may complicate the course of renal transplantation from the early weeks to up to 14 years after transplantation [<a href="#rid12">12,13</a>]. Immunosuppression, rejection and lymphatic blockade may be etiologic factors, and it may be difficult to distinguish XPN from rejection.</p><p class="headingAnchor" id="H7"><span class="h1">RADIOLOGIC DIAGNOSIS</span><span class="headingEndMark"> — </span>Although the urinalysis and urine culture typically indicate the presence of urinary tract infection, the diagnosis of XPN is confirmed by radiologic testing and pathology. Intravenous pyelography is abnormal but generally not diagnostic. It usually reveals the shadow of a nonfunctioning, enlarged kidney containing several renal stones or a staghorn calculus. In cases in which part of the kidney is still functioning, the IVP shows a space-occupying lesion resembling renal cancer.</p><p class="headingAnchor" id="H8"><span class="h2">CT scan</span><span class="headingEndMark"> — </span>Computed tomography (CT) scan has replaced renal angiography as the preferred diagnostic tool in the evaluation of XPN  (<a class="graphic graphic_diagnosticimage graphicRef70240" href="/d/graphic/70240.html" rel="external">image 1</a>). The CT scan has several advantages [<a href="#rid14">14</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>It shows the characteristic replacement of the renal tissue by several rounded, low-density (15 to 18 Hounsfield units) areas that are surrounded by an enhanced rim of contrast medium, resulting in a multiloculated appearance  (<a class="graphic graphic_diagnosticimage graphicRef120351" href="/d/graphic/120351.html" rel="external">image 2</a>). These findings are similar in appearance to the paw print of a bear and are known as the "bear's paw sign" [<a href="#rid15">15,16</a>]. The imaging abnormalities correspond to dilated calyces lined with necrotic xanthomatous tissue extending into the renal parenchyma. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>It can determine the extent of the lesion and any extension into the perirenal area. The extent of the lesion can be classified into three stages: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Stage 1 – Localized disease confined to renal parenchyma.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Stage 2 – Extent of inflammation involves the perinephric fat.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Stage 3 – Extent of inflammation involves the perinephric spaces and/or abdominal wall. In the most advanced forms, the mass of xanthogranulomatous tissue can involve the adjacent gastrointestinal tract, and fistulas may be created into the colon or duodenum [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Renal stones which, as noted above are a frequent cause of XPN, are clearly visible on CT scan films.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CT scan may disclose the infrequent association of XPN and renal cancer, with or without renal stones [<a href="#rid17">17</a>]. In those patients without stones, the malignancy may be a causative factor in XPN, probably through urinary tract obstruction.</p><p></p><p class="headingAnchor" id="H9"><span class="h1">PATHOLOGY</span><span class="headingEndMark"> — </span>XPN is almost always unilateral. On macroscopic examination, the kidney is enlarged and usually destroyed by the inflammatory process. Necrotic yellow material surrounded by layers of orange-colored tissue is typically seen  (<a class="graphic graphic_picture graphicRef80578" href="/d/graphic/80578.html" rel="external">picture 1</a>). Renal stones, including staghorn calculi, are usually present within the mass. The inflammatory tumor is adherent to the surrounding structures if there has been perirenal extension. Extension to the duodenum, the spleen, the lung and the skin is uncommon, but may lead to fistula formation and require extensive surgical intervention [<a href="#rid13">13</a>].</p><p>On microscopic examination, the lesion comprises three layers centered by a calyx [<a href="#rid18">18</a>]. The inner zone consists of necrosis, leukocytes, lymphocytes, plasma cells and macrophages. The middle zone contains vascularized granulation tissue interspersed with hemorrhage. The inflammatory cells are largely lipid-laden macrophages, which account for the yellow color  (<a class="graphic graphic_picture graphicRef59000" href="/d/graphic/59000.html" rel="external">picture 2</a>). The outermost part of the lesion is characterized by giant cells and cholesterol clefts [<a href="#rid14">14</a>].</p><p class="headingAnchor" id="H10"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>XPN is due to inflammation which may occur as a result of a defect in macrophage processing of bacteria. In the case of XPN complicating renal transplantation, renal ischemia, lymphatic blockade and immunosuppression may also be important factors [<a href="#rid12">12</a>]. The factors responsible for the accumulation of lipids and cholesterol in the lesion are not well understood.</p><p class="headingAnchor" id="H11"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>XPN is most frequently confused with renal carcinoma in its clinical presentation and radiographic appearance. There is also report of pulmonary septic emboli masquerading as metastatic malignancy [<a href="#rid19">19</a>]. Evidence of chronic urinary tract infection and CT scan findings usually facilitates differentiation of these disorders, although rarely the two can occur together. XPN must also be distinguished histologically from two other inflammatory conditions, renal parenchymal malakoplakia and megalocytic interstitial nephritis [<a href="#rid20">20</a>]. The clinical differential diagnosis is similar to that of renal abscess, although the imaging findings are distinct. (See  <a class="medical medical_review" href="/d/html/8057.html" rel="external">"Renal and perinephric abscess", section on 'Differential diagnosis'</a>.)</p><p class="headingAnchor" id="H12"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>XPN is almost always unilateral and is associated with virtually complete destruction of the kidney. Treatment is therefore surgical (after an initial course of antimicrobials to control the local infection) and consists of en-bloc nephrectomy, in which all the involved tissue is removed and any fistulas closed. Patients with a localized form (usually children) or with bilateral disease can be treated with partial nephrectomy [<a href="#rid21">21</a>]. Laparoscopic nephrectomy is a potential approach, depending on the extent of the lesions and the urologist's expertise [<a href="#rid22">22</a>].</p><p class="headingAnchor" id="H428243531"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/111611.html" rel="external">"Society guideline links: Urinary tract infections in adults"</a>.)</p><p class="headingAnchor" id="H14428451"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Xanthogranulomatous pyelonephritis (XPN) is an unusual variant of chronic pyelonephritis in which there is massive destruction of the kidney by granulomatous tissue containing lipid-laden macrophages. It is thought to be due to aberrant inflammation as a result of a macrophage defect in microbial processing. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In adults, xanthogranulomatous pyelonephritis most commonly occurs in middle-aged women with a history of recurrent urinary tract infections, particularly with <em>Escherichia coli</em>, <em>Proteus mirabilis</em>, <em>Pseudomonas aeruginosa</em>, <em>Enterococcus faecalis</em>, and <em>Klebsiella</em> species. In children, xanthogranulomatous pyelonephritis can involve the entire kidney or may be localized, mimicking a tumor, and is most commonly associated with <em>Proteus</em> and <em>E. coli</em>. Xanthogranulomatous pyelonephritis is a rare complication of renal transplantation. (See <a class="local">'Clinical presentation'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Presenting symptoms include flank or abdominal pain, fever, malaise, and weight loss or growth retardation. A unilateral renal mass can usually be palpated, and blood tests can reveal evidence of nonspecific systemic inflammation. In some cases, chronic inflammation can lead to secondary amyloidosis and the nephrotic syndrome. (See <a class="local">'Clinical presentation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The diagnosis is confirmed by characteristic findings on computed tomography (CT) scan and pathology. On CT, renal tissue appears replaced by several rounded low-density areas that are surrounded by an enhanced rim of contrast medium and correspond to dilated calyces lined with necrotic xanthomatous tissue  (<a class="graphic graphic_diagnosticimage graphicRef120351" href="/d/graphic/120351.html" rel="external">image 2</a>). (See <a class="local">'Radiologic diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>On gross examination, the kidney is enlarged with necrotic yellow material surrounded by layers of orange-colored tissue. Microscopically, the lesion consists of three layers of inflammatory cells surrounding the calyx. (See <a class="local">'Pathology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Xanthogranulomatous pyelonephritis is almost always unilateral and is most frequently confused clinically and radiographically with renal carcinoma. (See <a class="local">'Differential diagnosis'</a> above.).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Xanthogranulomatous pyelonephritis is treated with partial or full nephrectomy following an initial course of antibiotics to control the local infection. (See <a class="local">'Treatment'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Parsons MA, Harris SC, Longstaff AJ, Grainger RG. Xanthogranulomatous pyelonephritis: a pathological, clinical and aetiological analysis of 87 cases. Diagn Histopathol 1983; 6:203.</a></li><li><a class="nounderline abstract_t">Chuang CK, Lai MK, Chang PL, et al. Xanthogranulomatous pyelonephritis: experience in 36 cases. J Urol 1992; 147:333.</a></li><li><a class="nounderline abstract_t">Oosterhof GO, Delaere KP. Xanthogranulomatous pyelonephritis. A review with 2 case reports. Urol Int 1986; 41:180.</a></li><li><a class="nounderline abstract_t">Malek RS, Elder JS. Xanthogranulomatous pyelonephritis: a critical analysis of 26 cases and of the literature. J Urol 1978; 119:589.</a></li><li><a class="nounderline abstract_t">Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises case 2-1995. A 71-year-old man with masses in the pancreas, presacral region, and left kidney. N Engl J Med 1995; 332:174.</a></li><li><a class="nounderline abstract_t">Goodman M, Curry T, Russell T. Xanthogranulomatous pyelonephritis (XGP): a local disease with systemic manifestations. Report of 23 patients and review of the literature. Medicine (Baltimore) 1979; 58:171.</a></li><li><a class="nounderline abstract_t">Watt I, Roylance J. Pyonephrosis. Clin Radiol 1976; 27:513.</a></li><li><a class="nounderline abstract_t">Møller JC, Kristensen IB. Xanthogranulomatous pyelonephritis. A clinico-pathological study with special reference to pathogenesis. Acta Pathol Microbiol Scand A 1980; 88:89.</a></li><li><a class="nounderline abstract_t">Samuel M, Duffy P, Capps S, et al. Xanthogranulomatous pyelonephritis in childhood. J Pediatr Surg 2001; 36:598.</a></li><li><a class="nounderline abstract_t">Rao AG, Eberts PT. Xanthogranulomatous pyelonephritis: an uncommon pediatric renal mass. Pediatr Radiol 2011; 41:671.</a></li><li><a class="nounderline abstract_t">Lauzurica R, Felip A, Serra A, et al. Xanthogranulomatous pyelonephritis and systemic amyloidosis: report of 2 new cases and the natural history of this association. J Urol 1991; 146:1603.</a></li><li><a class="nounderline abstract_t">Parsons MA, Harris SC, Grainger RG, et al. Fistula and sinus formation in xanthogranulomatous pyelonephritis. A clinicopathological review and report of four cases. Br J Urol 1986; 58:488.</a></li><li><a class="nounderline abstract_t">Hitti W, Drachenberg C, Cooper M, et al. Xanthogranulomatous pyelonephritis in a renal allograft associated with xanthogranulomatous diverticulitis: report of the first case and review of the literature. Nephrol Dial Transplant 2007; 22:3344.</a></li><li><a class="nounderline abstract_t">Zorzos I, Moutzouris V, Korakianitis G, Katsou G. Analysis of 39 cases of xanthogranulomatous pyelonephritis with emphasis on CT findings. Scand J Urol Nephrol 2003; 37:342.</a></li><li><a class="nounderline abstract_t">Wu ST. Bear paw sign: classic presentation of xanthogranulomatous pyelonephritis. QJM 2019; 112:461.</a></li><li><a class="nounderline abstract_t">Garrido-Abad P, Rodríguez-Cabello MÁ, Vera-Berón R, Platas-Sancho A. Bear Paw Sign: Xanthogranulomatous Pyelonephritis. J Radiol Case Rep 2018; 12:18.</a></li><li><a class="nounderline abstract_t">Piscioli F, Luciani L. Association of xanthogranulomatous pyelonephritis with small renal cell carcinoma. Case report and review of the literature. Eur Urol 1984; 10:62.</a></li><li class="breakAll">Hill GS. Renal infection. In: Uropathology, 1st Ed, Hill GS (Ed), Churchill Livingstone, New York 1989. p.333.</li><li><a class="nounderline abstract_t">Hortling N, Layer G, Albers P, Schild HH. [Xanthogranulomatous pyelonephritis with septic lung metastases and infiltration of the colon. Difficult preoperative differential pulmonary hypernephroma metastasis diagnosis]. Aktuelle Radiol 1997; 7:317.</a></li><li><a class="nounderline abstract_t">al-Sulaiman MH, al-Khader AA, Mousa DH, et al. Renal parenchymal malacoplakia and megalocytic interstitial nephritis: clinical and histological features. Report of two cases and review of the literature. Am J Nephrol 1993; 13:483.</a></li><li><a class="nounderline abstract_t">Peréz LM, Thrasher JB, Anderson EE. Successful management of bilateral xanthogranulomatous pyelonephritis by bilateral partial nephrectomy. J Urol 1993; 149:100.</a></li><li><a class="nounderline abstract_t">Guzzo TJ, Bivalacqua TJ, Pierorazio PM, et al. Xanthogranulomatous pyelonephritis: presentation and management in the era of laparoscopy. BJU Int 2009; 104:1265.</a></li></ol></div><div id="topicVersionRevision">Topic 8058 Version 15.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6676075" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Xanthogranulomatous pyelonephritis: a pathological, clinical and aetiological analysis of 87 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1732587" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Xanthogranulomatous pyelonephritis: experience in 36 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3750578" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Xanthogranulomatous pyelonephritis. A review with 2 case reports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/660725" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Xanthogranulomatous pyelonephritis: a critical analysis of 26 cases and of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7800010" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises case 2-1995. A 71-year-old man with masses in the pancreas, presacral region, and left kidney.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/431402" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Xanthogranulomatous pyelonephritis (XGP): a local disease with systemic manifestations. Report of 23 patients and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1000895" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Pyonephrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7368938" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Xanthogranulomatous pyelonephritis. A clinico-pathological study with special reference to pathogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11283885" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Xanthogranulomatous pyelonephritis in childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21336642" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Xanthogranulomatous pyelonephritis: an uncommon pediatric renal mass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1942352" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Xanthogranulomatous pyelonephritis and systemic amyloidosis: report of 2 new cases and the natural history of this association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3779348" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Fistula and sinus formation in xanthogranulomatous pyelonephritis. A clinicopathological review and report of four cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17611245" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Xanthogranulomatous pyelonephritis in a renal allograft associated with xanthogranulomatous diverticulitis: report of the first case and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12944195" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Analysis of 39 cases of xanthogranulomatous pyelonephritis with emphasis on CT findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30597105" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Bear paw sign: classic presentation of xanthogranulomatous pyelonephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30647833" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Bear Paw Sign: Xanthogranulomatous Pyelonephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6698091" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Association of xanthogranulomatous pyelonephritis with small renal cell carcinoma. Case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6698091" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Association of xanthogranulomatous pyelonephritis with small renal cell carcinoma. Case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9467024" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : [Xanthogranulomatous pyelonephritis with septic lung metastases and infiltration of the colon. Difficult preoperative differential pulmonary hypernephroma metastasis diagnosis].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8141185" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Renal parenchymal malacoplakia and megalocytic interstitial nephritis: clinical and histological features. Report of two cases and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8417185" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Successful management of bilateral xanthogranulomatous pyelonephritis by bilateral partial nephrectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19389010" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Xanthogranulomatous pyelonephritis: presentation and management in the era of laparoscopy.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
